Navigation Links
Musculoskeletal Network Features Update on Nutraceuticals for Osteoarthritis
Date:8/24/2012

NORWALK, Conn., Aug. 24, 2012 /PRNewswire/ -- UBM Medica US today announced that Musculoskeletal Network, an online resource for unique and efficient techniques on the management of musculoskeletal disorders, now features an update on nutraceuticals and other nonpharmacological interventions for knee osteoarthritis.

Providing effective intervention to avoid long-term disability in osteoarthritis is difficult, say authors Vijay B. Vad, MD, Hospital for Special Surgery and Weill Cornell Medical College, and Stanley H. Dysart, MD, Pinnacle Orthopaedics & Sports Medicine Specialists. But studies of nonpharmacological interventions indicate they may help:

  • Meta-analyses have shown that administration of glucosamine/chondroitin sulfate can decrease joint-space narrowing and other radiographic markers of disease progression.
  • Adding omega-3 polyunsaturated fatty acids—eicosapentaenoic acid and docosahexaenoic acid—to glucosamine sulfate showed benefit when a criterion of pain reduction of 80% or greater was used.
  • A proprietary complex of curcumin with soy phosphatidylcholine has shown efficacy.

This is the second article in a 3-part osteoarthritis series on Musculoskeletal Network. Part 1 offered a rationale for early treatment. In the third article, the authors will provide an overview of systemic pharmacotherapy.

About UBM Medica US

Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach—online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, MusculoskeletalNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect – which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit http://www.UBMMEDICAUS.com

Media contact:
Jason J. Golden
Content Marketing Manager
203-523-7040
jason.golden@ubm.com


'/>"/>
SOURCE UBM Medica US
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Northwestern University Joins VIVO Network with Elseviers SciVal Experts
2. RIT professor receives National Science Foundation grant to improve on-chip networks with wireless technology
3. Pittcon 2013 Announces Call for Topics for Conferee Networking Sessions, August 1, 2012 Deadline
4. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
5. Aviir Laboratories Announce National Agreement with Three Rivers Provider Network
6. Autism mutations, scattered across many genes, merge into common network of interactions
7. Social networking shortcut to finding medical experts
8. Good Shepherd Rehabilitation Network Becomes Third Health-Care Organization in U.S. to Have Ekso Exoskeleton
9. Statewide Network of Angel Investor Groups Announced in Alabama
10. Self-assembling nanorods: Berkeley Lab researchers obtain 1-, 2- and 3-D nanorod arrays and networks
11. ConnectBiotech.org Launched, a Unique Life Science Business Networking Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... services spanning the full spectrum of drug and device development, and Prism ... pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has ...
Breaking Biology Technology:
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
(Date:12/22/2016)... YORK , December 22, 2016 ... provider of secure solutions for the e-Government, Public Safety, HealthCare, and ... subsidiary of SuperCom, has been selected to implement and deploy a ... in Northern California , further expanding its presence ... ...
(Date:12/19/2016)... 19 de diciembre de 2016  Mosaic Biomedicals SL anunció hoy ... de MSC-1, un anticuerpo humanizado que se espera comenzar a utilizar ... múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el primer ... leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos tumores ...
Breaking Biology News(10 mins):